BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 18803279)

  • 21. Lineage commitment in biphenotypic acute leukemia.
    Buccheri V; Matutes E; Dyer MJ; Catovsky D
    Leukemia; 1993 Jun; 7(6):919-27. PubMed ID: 8501986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunophenotyping of acute lymphatic leukemia: diagnostic aspects and clinical relevance].
    Ludwig WD; Reiter A; Schott G; Schwartz S; Thiel E
    Wien Klin Wochenschr; 1994; 106(8):231-2, 233-7. PubMed ID: 8023515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shifts in expression of immunological cell markers in relapsed acute leukemia.
    Tomová A; Babusíková O
    Neoplasma; 2001; 48(3):164-8. PubMed ID: 11583283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-kit receptor tyrosine kinase (CD117) expression and its positive predictive value for the diagnosis of Thai adult acute myeloid leukemia.
    Auewarakul CU; Lauhakirti D; Promsuwicha O; Munkhetvit C
    Ann Hematol; 2006 Feb; 85(2):108-12. PubMed ID: 16320053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The immunophenotypic and cytogenetic characteristics of the blast cells in subvariants of acute myeloid leukemia].
    Isakova LM; Tretiak NN; Khromiak VN; Gordienko AI; Zverkova AS; Vakul'chuk AM
    Tsitol Genet; 2000; 34(1):48-56. PubMed ID: 10808542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biphenotypic acute leukemia: a case report.
    Zucchini A; Fattori PP; Lanza F; Ferrari L; Bagli L; Imola M; Ravaioli A; Papa S
    J Biol Regul Homeost Agents; 2004; 18(3-4):387-91. PubMed ID: 15786709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.
    Zelezníková T; Babusíková O
    Neoplasma; 2006; 53(6):500-6. PubMed ID: 17167719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunophenotypes on blast cells of chronic myelogenous leukemia].
    Motoji T
    Nihon Rinsho; 2001 Dec; 59(12):2342-7. PubMed ID: 11766336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic quantitative features of patients with acute myeloid leukemia.
    Pereira FG; Metze K; Costa FP; Lima CS; Lorand-Metze I
    Neoplasma; 2006; 53(2):155-60. PubMed ID: 16575472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
    Kozlov I; Beason K; Yu C; Hughson M
    Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced myeloid specificity of CD117 compared with CD13 and CD33.
    Nomdedéu JF; Mateu R; Altès A; Llorente A; Rio C; Estivill C; López O; Ubeda J; Rubiol E
    Leuk Res; 1999 Apr; 23(4):341-7. PubMed ID: 10229319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.
    Zheng J; Wang X; Hu Y; Yang J; Liu J; He Y; Gong Q; Yao J; Li X; Du W; Huang S
    Cytometry B Clin Cytom; 2008 Jan; 74(1):25-9. PubMed ID: 18061959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid leukemia (AML-M0).
    Kotylo PK; Seo IS; Smith FO; Heerema NA; Fineberg NS; Miller K; Greene ME; Chou P; Orazi A
    Am J Clin Pathol; 2000 Feb; 113(2):193-200. PubMed ID: 10664621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-M0). Evaluation and a proposal.
    Kaleem Z; White G
    Am J Clin Pathol; 2001 Jun; 115(6):876-84. PubMed ID: 11392885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Four cases of CD7-positive acute myeloid leukemia].
    Tomiyama J; Mitsuhashi S; Kudo H; Adachi Y
    Rinsho Ketsueki; 1993 Jan; 34(1):57-62. PubMed ID: 8450609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of FAB classification of acute leukemias in era of immunophenotyping.
    Sachdeva MU; Ahluwalia J; Das R; Varma N; Garewal G
    Indian J Pathol Microbiol; 2006 Oct; 49(4):524-7. PubMed ID: 17183842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute biphenotypic leukemia in the adults.
    Shen Y; Li J; Xue Y; Zhu M; Lu D; Geng M; Ruan C
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):375-7. PubMed ID: 12408768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-CD10 immunoperoxidase staining of paraffin-embedded acute leukemias: comparison with flow cytometric immunophenotyping.
    Bavikatty NR; Ross CW; Finn WG; Schnitzer B; Singleton TP
    Hum Pathol; 2000 Sep; 31(9):1051-4. PubMed ID: 11014570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunophenotype of blast crisis in chronic myeloid leukemia].
    Favre G; Passweg J; Hoffmann T; Speck B; Gratwohl A; Tichelli A
    Schweiz Med Wochenschr; 1998 Oct; 128(42):1624-6. PubMed ID: 9824896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular cytogenetic findings of acute leukemia included in the Brazilian Collaborative Study Group of Infant acute leukemia.
    Emerenciano M; Agudelo Arias DP; Coser VM; de Brito GD; Macedo Silva ML; Pombo-de-Oliveira MS;
    Pediatr Blood Cancer; 2006 Oct; 47(5):549-54. PubMed ID: 16261608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.